[DIV28SUPER] Psychopharmacology of lycanthropy

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488342/?tool=pubmed

(happy Halloween!)

Sent from my iPhone

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Fwd: NIDA Neuroscience Update October 29, 2010

Sent from my iPhone

Begin forwarded message:

From: "NIDA NEURO SCIENCE (NIH/NIDA)" <nidaneurosc@MAIL.NIH.GOV>
Date: October 29, 2010 1:49:28 PM EDT
To: "NIDA_NEURO_SCIENCE-L@LIST.NIH.GOV" <NIDA_NEURO_SCIENCE-L@LIST.NIH.GOV>
Subject: NIDA Neuroscience Update October 29, 2010
Reply-To: "NIDA NEURO SCIENCE (NIH/NIDA)" <nidaneurosc@MAIL.NIH.GOV>

 

I. RFA-DA-11-004. A Funding Opportunity for Nicotine Dependence Medication (and Formulation) Development 

 

II. NIH Blueprint for Neuroscience: Training Grant Funding Opportunity Announcements (T90/R90)

 

III. Request for Information (RFI): Acquisition, Processing, Storage, and Distribution of Human Brain Tissues

 

IV. NIH Grant Workshop for Early Career Investigators at SfN

------

 

I. RFA-DA-11-004. A Funding Opportunity for Nicotine Dependence Medication (and Formulation) Development 

Applications Due:  January 13, 2011

 

Specific information can be obtained by visiting:  http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-004.html

 

The National Institute on Drug Abuse (NIDA) solicits applications for the development of novel treatments for nicotine dependence.  Up to $1.5M has been set aside to fund 4 or more meritorious small business technology transfer phase I (STTR) 1-year grants in FY2011!  Awardees would subsequently be eligible to apply for Phase II funding. Phase II projects can be supported at a level of ~$1M over two years and be competitively renewed. 

 

The STTR program ( http://grants.nih.gov/grants/funding/sbirsttr_programs.htm) is designed to fund collaborative projects between small businesses and non-profit research institutions. Its objectives are to move ideas from the laboratory into the marketplace and foster high-tech economic development. Because NIDA recognizes the potential complexity of establishing business-academic collaborations, NIDA staff will help cultivate these relationships for potential applicants.  

 

Please contact us if we can be of any assistance to you!

 

Kristopher Bough, PhD

NIDAmeddev@nida.nih.gov

 

 

II. NIH Blueprint for Neuroscience: Training Grant Funding Opportunity Announcements (T90/R90)

 

Training in Computational Neuroscience: From Biology to Model and Back Again

RFA-11-005

Letter of Intent Receipt Date: December 13, 2010

Application Receipt Date(s): January 13, 2011

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-005.html

 

This funding opportunity will support programs in computational neuroscience that provide research training and research education in both experimental neuroscience and in the theories and principles of the physical, computer, mathematical, or engineering sciences that are necessary to develop models, test them experimentally, and use experimental data to refine the models of neural systems or neuronal function.  Each training program must have two components: a] a full-time undergraduate research education program (R90), and b] a pre-doctoral NRSA institutional training program (T90). Programs may also include:  a full-time non-NRSA institutional pre-doctoral training component (R90) and/or a short course or summer course that may be open to scientists at any stage of the career continuum, from the grantee institution as well as other institutions (R90).

 

Training in Neuroimaging: Integrating First Principles and Applications

RFA-DA-11-006

Letter of Intent Receipt Date: December 13, 2010

Application Receipt Date(s): January 13, 2011

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-006.html

 

This funding opportunity will support novel, interdisciplinary training programs that integrate comprehensive training in basic neuroscience, the physical and biological bases of neuroimaging, the technologies of in vivo neuroimaging, and the application of these technologies to understanding questions in neuroscience across the life span.  Each training program must have two components: a] a pre-doctoral NRSA institutional training program (T90) and b] a short-term research education program (R90) that may include scientists at any stage of the career continuum who are interested in neuroimaging.  Programs may also include a full-time non-NRSA institutional pre-doctoral training component (R90).

 

 

III. Request for Information (RFI): Acquisition, Processing, Storage, and Distribution of Human Brain Tissues

 

The National Institute of Mental Health (NIMH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), National Institute on Aging (NIA), and National Institute of Neurological Disorders and Stroke (NINDS) recognize that human Brain Tissue Repositories (BTR) can contribute to the advancement of many aspects of research in addiction, developmental disorders, mental illness, neurological diseases, and aging.  To facilitate collaborative research and enhance the ability of BTR to serve a diverse set of constituents, these institutes are evaluating existing collections and the possibility of new approaches to acquiring, storing, and distributing these important tissues, through collaborations and partnerships with other organizations, foundations and/or groups.  The participating Institutes also anticipate discussions with those who maintain other similar human tissue repositories to develop common collection protocols, QA/QC standards, processing, storage, and distribution policies and procedures for specimens and associated data.  This Request for Information (RFI) serves to gather information about these topics from the research, advocacy, and other stakeholder communities.

 

For more details on information and how to respond to this request please go to: http://grants.nih.gov/grants/guide/notice-files/NOT-MH-10-034.html

 

 

IV. NIH Grant Workshop for Early Career Investigators at SfN

 

Date & Time: Monday, November 15, 6:30 PM - 10:00 PM
Location: San Diego Marriott Hotel and Marina
Room: Rancho Las Palmas
Organized By:

Calling all postdocs, new faculty, junior faculty- Do you seek research training, additional career development, or your first research project grant? Do you have questions about the NIH and the funding of grant applications? Would you like to speak face-to-face with NIH staff about preparing and submitting a grant application to the NIH? Then this is the workshop that you should be attending. The National Institute on Drug Abuse (NIDA)  is hosting this informational workshop as an opportunity for early career investigators to learn about the NIH and its grants process. From this workshop you will be able to get the information that will position you to successfully obtain NIH grant support for your training and research activities.

 

Contact: Nancy Pilotte
Natl Inst on Drug Abuse, NIH
Phone: (301) 443-1887

E-mail:  npilotte@nih.gov

Web site: www.nida.nih.gov/about/organization/DBNBR/PICNRB.html

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

 

http://list.nih.gov/cgi-bin/wa?SUBED1=nida_neuro_science-l&A=1&X=6F4BAE4CF706755A29&Y=nidaneurosc%40mail.nih.gov&A=0

[DIV28SUPER] NIDA Neuroscience Update October 29, 2010

 

I. RFA-DA-11-004. A Funding Opportunity for Nicotine Dependence Medication (and Formulation) Development 

 

II. NIH Blueprint for Neuroscience: Training Grant Funding Opportunity Announcements (T90/R90)

 

III. Request for Information (RFI): Acquisition, Processing, Storage, and Distribution of Human Brain Tissues

 

IV. NIH Grant Workshop for Early Career Investigators at SfN

------

 

I. RFA-DA-11-004. A Funding Opportunity for Nicotine Dependence Medication (and Formulation) Development 

Applications Due:  January 13, 2011

 

Specific information can be obtained by visiting:  http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-004.html

 

The National Institute on Drug Abuse (NIDA) solicits applications for the development of novel treatments for nicotine dependence.  Up to $1.5M has been set aside to fund 4 or more meritorious small business technology transfer phase I (STTR) 1-year grants in FY2011!  Awardees would subsequently be eligible to apply for Phase II funding. Phase II projects can be supported at a level of ~$1M over two years and be competitively renewed. 

 

The STTR program ( http://grants.nih.gov/grants/funding/sbirsttr_programs.htm) is designed to fund collaborative projects between small businesses and non-profit research institutions. Its objectives are to move ideas from the laboratory into the marketplace and foster high-tech economic development. Because NIDA recognizes the potential complexity of establishing business-academic collaborations, NIDA staff will help cultivate these relationships for potential applicants.  

 

Please contact us if we can be of any assistance to you!

 

Kristopher Bough, PhD

NIDAmeddev@nida.nih.gov

 

 

II. NIH Blueprint for Neuroscience: Training Grant Funding Opportunity Announcements (T90/R90)

 

Training in Computational Neuroscience: From Biology to Model and Back Again

RFA-11-005

Letter of Intent Receipt Date: December 13, 2010

Application Receipt Date(s): January 13, 2011

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-005.html

 

This funding opportunity will support programs in computational neuroscience that provide research training and research education in both experimental neuroscience and in the theories and principles of the physical, computer, mathematical, or engineering sciences that are necessary to develop models, test them experimentally, and use experimental data to refine the models of neural systems or neuronal function.  Each training program must have two components: a] a full-time undergraduate research education program (R90), and b] a pre-doctoral NRSA institutional training program (T90). Programs may also include:  a full-time non-NRSA institutional pre-doctoral training component (R90) and/or a short course or summer course that may be open to scientists at any stage of the career continuum, from the grantee institution as well as other institutions (R90).

 

Training in Neuroimaging: Integrating First Principles and Applications

RFA-DA-11-006

Letter of Intent Receipt Date: December 13, 2010

Application Receipt Date(s): January 13, 2011

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-006.html

 

This funding opportunity will support novel, interdisciplinary training programs that integrate comprehensive training in basic neuroscience, the physical and biological bases of neuroimaging, the technologies of in vivo neuroimaging, and the application of these technologies to understanding questions in neuroscience across the life span.  Each training program must have two components: a] a pre-doctoral NRSA institutional training program (T90) and b] a short-term research education program (R90) that may include scientists at any stage of the career continuum who are interested in neuroimaging.  Programs may also include a full-time non-NRSA institutional pre-doctoral training component (R90).

 

 

III. Request for Information (RFI): Acquisition, Processing, Storage, and Distribution of Human Brain Tissues

 

The National Institute of Mental Health (NIMH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), National Institute on Aging (NIA), and National Institute of Neurological Disorders and Stroke (NINDS) recognize that human Brain Tissue Repositories (BTR) can contribute to the advancement of many aspects of research in addiction, developmental disorders, mental illness, neurological diseases, and aging.  To facilitate collaborative research and enhance the ability of BTR to serve a diverse set of constituents, these institutes are evaluating existing collections and the possibility of new approaches to acquiring, storing, and distributing these important tissues, through collaborations and partnerships with other organizations, foundations and/or groups.  The participating Institutes also anticipate discussions with those who maintain other similar human tissue repositories to develop common collection protocols, QA/QC standards, processing, storage, and distribution policies and procedures for specimens and associated data.  This Request for Information (RFI) serves to gather information about these topics from the research, advocacy, and other stakeholder communities.

 

For more details on information and how to respond to this request please go to: http://grants.nih.gov/grants/guide/notice-files/NOT-MH-10-034.html

 

 

IV. NIH Grant Workshop for Early Career Investigators at SfN

 

Date & Time: Monday, November 15, 6:30 PM - 10:00 PM
Location: San Diego Marriott Hotel and Marina
Room: Rancho Las Palmas
Organized By:

Calling all postdocs, new faculty, junior faculty- Do you seek research training, additional career development, or your first research project grant? Do you have questions about the NIH and the funding of grant applications? Would you like to speak face-to-face with NIH staff about preparing and submitting a grant application to the NIH? Then this is the workshop that you should be attending. The National Institute on Drug Abuse (NIDA)  is hosting this informational workshop as an opportunity for early career investigators to learn about the NIH and its grants process. From this workshop you will be able to get the information that will position you to successfully obtain NIH grant support for your training and research activities.

 

Contact: Nancy Pilotte
Natl Inst on Drug Abuse, NIH
Phone: (301) 443-1887

E-mail:  npilotte@nih.gov

Web site: www.nida.nih.gov/about/organization/DBNBR/PICNRB.html

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

 

[DIV28SUPER] Fwd: NIDA Neuroscience Update, October 20, 2010

Sent from my iPhone

Begin forwarded message:

From: "NIDA NEURO SCIENCE (NIH/NIDA)" <nidaneurosc@MAIL.NIH.GOV>
Date: October 19, 2010 11:20:32 PM EDT
To: "NIDA_NEURO_SCIENCE-L@LIST.NIH.GOV" <NIDA_NEURO_SCIENCE-L@LIST.NIH.GOV>
Subject: NIDA Neuroscience Update, October 20, 2010
Reply-To: "NIDA NEURO SCIENCE (NIH/NIDA)" <nidaneurosc@MAIL.NIH.GOV>

 

Table of Contents

 

I.   Last Call to Register: NIDA/SfN Mini-Convention: Frontiers in Addiction Research

 

II.  NIDA Encourages NIDA funded PIs to identify NIDA supported graduate students for nomination to attend 61^st annual meeting of Nobel Laureates in Lindau, Germany

 

III.  RFA: Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21)

 

IV.  Neuroscience Research on Drug Abuse PA

------

 

 

I.  Last Call to Register:  NIDA/SfN Mini-Convention: Frontiers in Addiction Research

Date & Time: Friday, November 12, 8:00 AM - 6:20 PM
Location: San Diego Marriott Hotel and Marina
Room: Marriott Hall

Online registration: www.seiservices.com/nida/frontiers2010/ 

Online registration closes October 29- space is limited

 

The National Institute on Drug Abuse (NIDA) Mini-Convention, Frontiers in Addiction Research, will feature cutting-edge presentations and discussion of future directions in the neurobiology of drug abuse and addiction. The NIDA Mini-Convention includes four symposia, the SfN Jacob Waletzky Memorial Lecture and a poster session featuring early career investigators.

 

II. NIDA Encourages NIDA funded PIs to identify NIDA supported graduate students for nomination to attend 61^st annual meeting of Nobel Laureates in Lindau, Germany

The Department of Energy (DOE) and the National Institutes of Health (NIH) are pleased to announce that they will nominate and sponsor a maximum of 55 graduate students to attend the 61^st annual meeting of Nobel Laureates and students in Lindau, Germany, from June 26 through July 1, 2011. This year, we are increasing the number of applications accepted by the sponsors.   We invite your institution to nominate up to two students for each sponsor to be considered for this very exciting opportunity. 

 

All nominations must be submitted online before Monday, November 1, 2010 at 4:00 pm, Eastern Time.  Nominees will be notified by December 1, 2010 whether they have been selected. An information sheet on the program is enclosed. Further information about the program, including the Web site for submission of nominations, can be found online beginning on October 1, 2010 at http://www.orau.org/lindau/.

 

Since 1951, Nobel Prize winners and students in chemistry, physics, and physiology or medicine have met annually in Lindau, located on Lake Constance in southwestern Germany. It is anticipated that some 550 students from more than 70 countries will attend the weeklong meeting in 2011. There are formal lectures in the morning, and the remainder of the day is set aside for the students to meet informally with the Nobel Laureate scientists, as well as with their fellow students from around the world. Information on the most recent meeting and comments from students who attended are available at http://www.orau.org/lindau/past-mtgs/default.shtml.

 

In 2011, the meeting will feature recipients of the Nobel Prize in Physiology or Medicine. You may nominate students to attend this meeting who:

 

·         are U.S. citizens currently enrolled at a university as full-time graduate students;

·         have completed by June 2011 at least two years of graduate studies and not more than four years in physiology, medicine, or in a related field, including the basic biomedical (or life) sciences;

·         be supported by and/or working on a project, grant, or fellowship sponsored by the Department of Energy Office of Science (DOE-SC) or the National Institutes of Health (NIH).

 

We are especially interested in receiving nominations from a diverse group of students, including women, minorities and people with disabilities.

 

DOE and NIH will again partner this year with ORAU and Mars, Incorporated.  Those organizations are separately announcing their nomination processes, but will also accept two nominations as well. 

 

The selection process for the Lindau Meeting occurs over three phases.  The universities and National Laboratories complete the first phase by selecting two students per sponsor and submitting the nomination packet for each student.  DOE and NIH complete phase two by selecting the students to nominate to the Lindau Meeting.  The final phase of selection is completed by the Lindau Meeting and its screening process. All three phases ultimately adhere to the Lindau Meeting's selection criteria, which is attached with this e-mail message.

 

All nominations must be submitted online before Monday, November 1, 2010 at 4:00 pm, Eastern Time.  Nominees will be notified by December 1, 2010 whether they have been selected. An information sheet on the program is enclosed. Further information about the program, including the Web site for submission of nominations, can be found online beginning on October 1, 2010 at http://www.orau.org/lindau/.

 

You may delegate responsibility for submitting nominations to another office in your institution.

However, individual faculty members may not submit nominations directly. If you have any questions or need further information, please contact one of us using the contact information below.

 

Best Regards,

 

William J. Valdez                                                                      Michael Rogers

Director, Workforce Development                                 Director, Pharmacology, Physiology, and Biological Chemistry Division

Office of Science                                                                 National Institute of General Medical Sciences

U.S. Department of Energy                                                 National Institutes of Health

865-576-8223 (Sam Held)                                                  301-594-3827

sam.held@orau.org                                                             rogersm@nigms.nih.gov

 

 

 

III. Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21)

Application Due Date(s):  January 18, 2011
Peer Review Date(s): February/March 2011
Council Review Date(s): May 2011
Earliest Anticipated Start Date(s):  July 2011 

URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-007.html

 

Purpose.  This FOA, issued by the National Institute on Drug Abuse (NIDA), requests applications that propose to develop biological assays that will facilitate the discovery of new molecular probes for investigating the biological function of neuronal nicotinic acetylcholine receptors (nAChRs).   Membrane-spanning subunits (alpha and beta) aggregate in pentamers to form various combinations of functional nAChR ion channels.  Genetic association studies have implicated variants in the α5-α3-β4 cholinergic nicotinic receptor subunit gene cluster on chromosome 15q24-25.1 for the risk of nicotine addiction, tobacco dependence, smoking, and lung cancer.  Other studies have implicated the α6-subunit in nicotine addiction.  This FOA seeks applications proposing to develop biological assays for constitutive receptor combinations involving α3, α5, α6, and/or β4 subunits, suitable ultimately for configuration as high throughput screening (HTS) assays. 

Mechanism of Support. The NIH Exploratory/Developmental (R21) with modifications.

Funds Available and Anticipated Number of Awards.  Approximately $1.5 million will be available. NIDA anticipates making approximately 5-7 awards in 2011..

Budget and Project Period:  The total project period for an application submitted in response to this funding opportunity may not exceed one year.  Direct costs are limited to $150,000.  

 

 

IV. Title:  Neuroscience Research on Drug Abuse PA

Application Due Dates:  see http://grants.nih.gov/grants/funding/submissionschedule.htm

Purpose: This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages Research applications from institutions/ organizations that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans.  See PA for more details: http://grants.nih.gov/grants/guide/pa-files/PA-10-268.html (R01); http://grants.nih.gov/grants/guide/pa-files/PA-10-269.html (R21); http://grants.nih.gov/grants/guide/pa-files/PA-10-270.html (R03).

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

 

http://list.nih.gov/cgi-bin/wa?SUBED1=nida_neuro_science-l&A=1&X=6F4BAE4CF706755A29&Y=nidaneurosc%40mail.nih.gov&A=0

[DIV28SUPER] NIDA Neuroscience Update, October 20, 2010

 

Table of Contents

 

I.   Last Call to Register: NIDA/SfN Mini-Convention: Frontiers in Addiction Research

 

II.  NIDA Encourages NIDA funded PIs to identify NIDA supported graduate students for nomination to attend 61^st annual meeting of Nobel Laureates in Lindau, Germany

 

III.  RFA: Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21)

 

IV.  Neuroscience Research on Drug Abuse PA

------

 

 

I.  Last Call to Register:  NIDA/SfN Mini-Convention: Frontiers in Addiction Research

Date & Time: Friday, November 12, 8:00 AM - 6:20 PM
Location: San Diego Marriott Hotel and Marina
Room: Marriott Hall

Online registration: www.seiservices.com/nida/frontiers2010/ 

Online registration closes October 29- space is limited

 

The National Institute on Drug Abuse (NIDA) Mini-Convention, Frontiers in Addiction Research, will feature cutting-edge presentations and discussion of future directions in the neurobiology of drug abuse and addiction. The NIDA Mini-Convention includes four symposia, the SfN Jacob Waletzky Memorial Lecture and a poster session featuring early career investigators.

 

II. NIDA Encourages NIDA funded PIs to identify NIDA supported graduate students for nomination to attend 61^st annual meeting of Nobel Laureates in Lindau, Germany

The Department of Energy (DOE) and the National Institutes of Health (NIH) are pleased to announce that they will nominate and sponsor a maximum of 55 graduate students to attend the 61^st annual meeting of Nobel Laureates and students in Lindau, Germany, from June 26 through July 1, 2011. This year, we are increasing the number of applications accepted by the sponsors.   We invite your institution to nominate up to two students for each sponsor to be considered for this very exciting opportunity. 

 

All nominations must be submitted online before Monday, November 1, 2010 at 4:00 pm, Eastern Time.  Nominees will be notified by December 1, 2010 whether they have been selected. An information sheet on the program is enclosed. Further information about the program, including the Web site for submission of nominations, can be found online beginning on October 1, 2010 at http://www.orau.org/lindau/.

 

Since 1951, Nobel Prize winners and students in chemistry, physics, and physiology or medicine have met annually in Lindau, located on Lake Constance in southwestern Germany. It is anticipated that some 550 students from more than 70 countries will attend the weeklong meeting in 2011. There are formal lectures in the morning, and the remainder of the day is set aside for the students to meet informally with the Nobel Laureate scientists, as well as with their fellow students from around the world. Information on the most recent meeting and comments from students who attended are available at http://www.orau.org/lindau/past-mtgs/default.shtml.

 

In 2011, the meeting will feature recipients of the Nobel Prize in Physiology or Medicine. You may nominate students to attend this meeting who:

 

·         are U.S. citizens currently enrolled at a university as full-time graduate students;

·         have completed by June 2011 at least two years of graduate studies and not more than four years in physiology, medicine, or in a related field, including the basic biomedical (or life) sciences;

·         be supported by and/or working on a project, grant, or fellowship sponsored by the Department of Energy Office of Science (DOE-SC) or the National Institutes of Health (NIH).

 

We are especially interested in receiving nominations from a diverse group of students, including women, minorities and people with disabilities.

 

DOE and NIH will again partner this year with ORAU and Mars, Incorporated.  Those organizations are separately announcing their nomination processes, but will also accept two nominations as well. 

 

The selection process for the Lindau Meeting occurs over three phases.  The universities and National Laboratories complete the first phase by selecting two students per sponsor and submitting the nomination packet for each student.  DOE and NIH complete phase two by selecting the students to nominate to the Lindau Meeting.  The final phase of selection is completed by the Lindau Meeting and its screening process. All three phases ultimately adhere to the Lindau Meeting’s selection criteria, which is attached with this e-mail message.

 

All nominations must be submitted online before Monday, November 1, 2010 at 4:00 pm, Eastern Time.  Nominees will be notified by December 1, 2010 whether they have been selected. An information sheet on the program is enclosed. Further information about the program, including the Web site for submission of nominations, can be found online beginning on October 1, 2010 at http://www.orau.org/lindau/.

 

You may delegate responsibility for submitting nominations to another office in your institution.

However, individual faculty members may not submit nominations directly. If you have any questions or need further information, please contact one of us using the contact information below.

 

Best Regards,

 

William J. Valdez                                                                      Michael Rogers

Director, Workforce Development                                 Director, Pharmacology, Physiology, and Biological Chemistry Division

Office of Science                                                                 National Institute of General Medical Sciences

U.S. Department of Energy                                                 National Institutes of Health

865-576-8223 (Sam Held)                                                  301-594-3827

sam.held@orau.org                                                             rogersm@nigms.nih.gov

 

 

 

III. Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21)

Application Due Date(s):  January 18, 2011
Peer Review Date(s): February/March 2011
Council Review Date(s): May 2011
Earliest Anticipated Start Date(s):  July 2011 

URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-11-007.html

 

Purpose.  This FOA, issued by the National Institute on Drug Abuse (NIDA), requests applications that propose to develop biological assays that will facilitate the discovery of new molecular probes for investigating the biological function of neuronal nicotinic acetylcholine receptors (nAChRs).   Membrane-spanning subunits (alpha and beta) aggregate in pentamers to form various combinations of functional nAChR ion channels.  Genetic association studies have implicated variants in the α5-α3-β4 cholinergic nicotinic receptor subunit gene cluster on chromosome 15q24-25.1 for the risk of nicotine addiction, tobacco dependence, smoking, and lung cancer.  Other studies have implicated the α6-subunit in nicotine addiction.  This FOA seeks applications proposing to develop biological assays for constitutive receptor combinations involving α3, α5, α6, and/or β4 subunits, suitable ultimately for configuration as high throughput screening (HTS) assays. 

Mechanism of Support. The NIH Exploratory/Developmental (R21) with modifications.

Funds Available and Anticipated Number of Awards.  Approximately $1.5 million will be available. NIDA anticipates making approximately 5-7 awards in 2011..

Budget and Project Period:  The total project period for an application submitted in response to this funding opportunity may not exceed one year.  Direct costs are limited to $150,000.  

 

 

IV. Title:  Neuroscience Research on Drug Abuse PA

Application Due Dates:  see http://grants.nih.gov/grants/funding/submissionschedule.htm

Purpose: This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages Research applications from institutions/ organizations that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction, including use, dependence, addiction, withdrawal, and treatment, and may be conducted using model systems, animals, and/or humans.  See PA for more details: http://grants.nih.gov/grants/guide/pa-files/PA-10-268.html (R01); http://grants.nih.gov/grants/guide/pa-files/PA-10-269.html (R21); http://grants.nih.gov/grants/guide/pa-files/PA-10-270.html (R03).

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

 

[DIV28SUPER] Faculty position at UNL

Please share widely with trainees and colleagues—Thanks! RIck

 

 

The Department of Psychology, University of Nebraska-Lincoln (www.unl.edu/psypage) seeks to fill a tenure-track, Assistant to Associate Professor position beginning August, 2011. The position is designed for a scholar in any area who specializes in Latino/a issues. Responsibilities include maintaining an active research program with a track record of publications and grants; teaching graduate and undergraduate courses. Qualifications include Ph.D. in psychology or equivalent, record of achievement in scholarship and teaching, expertise in Latinos/as with preference in health issues, such as mental and behavioral pathology, risk and resilience, substance use, aggression, social competence, academic adjustment, acculturative stress, and/or coping. Review of applications will begin November 1, 2010 and continue until position is filled. Send letter of application, vita, reprints, and three letters of recommendation to: Brian Wilcox, Chair, Latino Scholar Search Committee, Department of Psychology, 238 Burnett Hall, University of Nebraska-Lincoln, Lincoln, NE, 68588-0308. To be considered for the position the online application form at http://employment.unl.edu, requisition #100464 must also be completed. The University of Nebraska has an active National Science Foundation ADVANCE gender equity program, and is committed to a pluralistic campus community through affirmative action, equal opportunity, work-life balance and dual careers. Contact Claudia Price-Decker at (402) 472-3721 for assistance.

 

 

 

 

 

Rick A. Bevins, Ph.D.

Vice Chair & Professor of Psychology

 

Burnett Hall

Department of Psychology

University of Nebraska-Lincoln

Lincoln, NE 68588-0308  USA

 

Ph: 402.472.1189  Fax: 402.472.4637

e-mail: rbevins1@unl.edu

lab: www.unl.edu/psychoneuropharm/

dept: http://psych.unl.edu/faculty/faculty.asp?id=16

SARC: http://groups.google.com/group/nebraska-SARC
Substance Abuse Research Cluster

 

 

[DIV28SUPER] @LATimesscience, 10/10/10 3:04 AM

Level-headed reportage. What's critical is regulation and health surveillance. With increased utilization of any chemical in large populations adverse events appear. Will there be a regulatory process like that emerging at FDA for tobacco?

A. Budney comments in this article

LA Times Science (@LATimesscience) 10/10/10 3:04 AM A bit of tarnish on marijuana's benign reputation http://lat.ms/aINuk9

Sent from my iPhone

[DIV28M] Postdoctoral Position at UCSF

POSTDOCTORAL SCHOLARS: One- to two-year NIH/NIDA-funded positions as postdoctoral scholars in drug abuse treatment and services research are available in a multidisciplinary research environment in the Department of Psychiatry, University of California, San Francisco. Scholars work with a preceptor to design and implement studies on the treatment of drug dependence, and select a specific area of focus for independent research. Director and Associate Director Drs. James Sorensen and Sharon Hall and Co-Directors Drs. Steven Batki, Kevin Delucchi, Joseph Guydish, Carmen Masson, and Constance Weisner are all involved with either the NIDA Clinical Trials Network (CTN) or Treatment Research Center (TRC). Training of psychiatrists, women, and minorities for academic research careers is a priority. Send CV, research statement, samples of work, and two (2) letters of recommendation to Barbara Paschke, 2727 Mariposa Street, Suite 100, San Francisco, CA 94110; 415-437-3032; Barbara.paschke@ucsf.edu. Additional information including faculty research interests is available at: http://ucsftrc.autoupdate.com/post_doctoral_program.vp.html

-------------------------------------------------------------------------------------------------
William W. Stoops, Ph.D.
Assistant Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are
confidential and are intended solely for the addressee. The information
may also be legally privileged. This transmission is sent in trust, for
the sole purpose of delivery to the intended recipient. If you have
received this transmission in error, any use, reproduction or
dissemination of this transmission is strictly prohibited. If you are
not the intended recipient, please immediately notify the sender by
reply e-mail or at (859) 257-5383 and delete this message and its
attachments, if any.
__________________ Div28m@lists.apa.org ___________________
restricted to APA members subscribers corner: http://lists.apa.org

[DIV28M] Faculty Position in the University of Kentucky Department of Psychology

Assistant or Associate Professor in Human Neuroscience. The University of Kentucky Department of Psychology invites applications for a tenure track position at the assistant or associate level to begin Fall, 2011. Candidates must be experienced using fMRI. Their substantive interests may be in any existing research program in the department (behavioral neuroscience, clinical, cognitive, developmental, social). However, candidates must also be willing to collaborate with faculty in the Center for Drug Abuse Research Translation (http://www.uky.edu/Research/CDART/) doing research on substance abuse and/or its prevention in developing populations (i.e., children, adolescents and young adults). We seek applicants with a strong research program, potential to attract extramural funding, and commitment to excellent mentoring and teaching. Please submit a vita, statements of research and teaching interests, reprints and preprints, and arrange for three letters of reference to be sent to: Human Neuroscience Search Committee, Department of Psychology, 115 Kastle Hall, University of Kentucky, Lexington, KY 40506-0044. The application deadline is January 15, 2010. The University of Kentucky is a Carnegie Doctoral/Research University—Extensive, and the Department of Psychology has been identified as a Target of Opportunity within the University. The University of Kentucky is an Affirmative Action/Equal Opportunity University that values diversity and is located in an increasingly diverse geographical region. It is committed to becoming one of the top public institutions in the country. Women, persons with disabilities, and members of other underrepresented groups are encouraged to apply. The University supports family-friendly policies.

Formal Position Description
The successful candidate for the position in "human neuroscience" must meet the following criteria:
1. Must have earned a Ph.D. in psychology or closely-related field;
2. Must be experienced in using fMRI;
3. Must be willing to collaborate on research with faculty in the Center for Drug Abuse Research Translation (CDART) doing research on substance abuse and/or its prevention in developing populations (i.e., children, adolescents and young adults);
4. The substantive interests of the candidate may be in any area that makes contact with existing research programs in the department (behavioral neuroscience, clinical, cognitive, developmental, social);
5. Must have established a strong research program;
6. Must show potential to attract extramural funding;
7. Must demonstrate a commitment to excellent mentoring and teaching;
8. Will be hired at the assistant or associate professor level.

-------------------------------------------------------------------------------------------------
William W. Stoops, Ph.D.
Assistant Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are
confidential and are intended solely for the addressee. The information
may also be legally privileged. This transmission is sent in trust, for
the sole purpose of delivery to the intended recipient. If you have
received this transmission in error, any use, reproduction or
dissemination of this transmission is strictly prohibited. If you are
not the intended recipient, please immediately notify the sender by
reply e-mail or at (859) 257-5383 and delete this message and its
attachments, if any.
__________________ Div28m@lists.apa.org ___________________
restricted to APA members subscribers corner: http://lists.apa.org